JPH02222677A - Purine nucleoside phosphorylase and production thereof - Google Patents
Purine nucleoside phosphorylase and production thereofInfo
- Publication number
- JPH02222677A JPH02222677A JP4020889A JP4020889A JPH02222677A JP H02222677 A JPH02222677 A JP H02222677A JP 4020889 A JP4020889 A JP 4020889A JP 4020889 A JP4020889 A JP 4020889A JP H02222677 A JPH02222677 A JP H02222677A
- Authority
- JP
- Japan
- Prior art keywords
- purine nucleoside
- minutes
- treatment
- solution
- potassium phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 title claims abstract description 22
- 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 17
- 108090000790 Enzymes Proteins 0.000 claims abstract description 17
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims abstract description 8
- 239000002212 purine nucleoside Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 5
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 claims abstract description 5
- 229930024421 Adenine Natural products 0.000 claims abstract description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims abstract description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims abstract description 4
- 229960000643 adenine Drugs 0.000 claims abstract description 4
- 229960005305 adenosine Drugs 0.000 claims abstract description 4
- 238000001962 electrophoresis Methods 0.000 claims abstract description 4
- 244000005700 microbiome Species 0.000 claims abstract description 4
- 239000000758 substrate Substances 0.000 claims abstract description 4
- 230000002779 inactivation Effects 0.000 claims abstract description 3
- 230000005764 inhibitory process Effects 0.000 claims description 5
- YXJDFQJKERBOBM-TXICZTDVSA-N alpha-D-ribose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O YXJDFQJKERBOBM-TXICZTDVSA-N 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 3
- 238000002523 gelfiltration Methods 0.000 claims description 3
- 230000006641 stabilisation Effects 0.000 claims description 3
- 238000011105 stabilization Methods 0.000 claims description 3
- 239000012190 activator Substances 0.000 claims description 2
- 229960002523 mercuric chloride Drugs 0.000 claims description 2
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 241000193385 Geobacillus stearothermophilus Species 0.000 abstract description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical class N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 1
- 230000036632 reaction speed Effects 0.000 abstract 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 64
- 239000000243 solution Substances 0.000 description 37
- 229910000160 potassium phosphate Inorganic materials 0.000 description 32
- 235000011009 potassium phosphates Nutrition 0.000 description 32
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 229930010555 Inosine Natural products 0.000 description 5
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 5
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical compound [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 229960003786 inosine Drugs 0.000 description 5
- 239000002777 nucleoside Substances 0.000 description 5
- 150000003833 nucleoside derivatives Chemical class 0.000 description 5
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108700006317 Purine-nucleoside phosphorylases Proteins 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 230000009229 glucose formation Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229940075420 xanthine Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- ALBODLTZUXKBGZ-JUUVMNCLSA-N (2s)-2-amino-3-phenylpropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 ALBODLTZUXKBGZ-JUUVMNCLSA-N 0.000 description 1
- ODDDVFDZBGTKDX-VPCXQMTMSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-methyloxolan-2-yl]pyrimidine-2,4-dione Chemical compound C1=CC(=O)NC(=O)N1[C@]1(C)O[C@H](CO)[C@@H](O)[C@H]1O ODDDVFDZBGTKDX-VPCXQMTMSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- OLXZPDWKRNYJJZ-RRKCRQDMSA-N 2'-deoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 OLXZPDWKRNYJJZ-RRKCRQDMSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- YKBGVTZYEHREMT-UHFFFAOYSA-N 2'-deoxyguanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1CC(O)C(CO)O1 YKBGVTZYEHREMT-UHFFFAOYSA-N 0.000 description 1
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
- BMGWZHWESYHXHC-UHFFFAOYSA-N 2-amino-3-methylpentanoic acid;2-amino-4-methylpentanoic acid Chemical compound CCC(C)C(N)C(O)=O.CC(C)CC(N)C(O)=O BMGWZHWESYHXHC-UHFFFAOYSA-N 0.000 description 1
- LQJAALCCPOTJGB-YUMQZZPRSA-N Arg-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O LQJAALCCPOTJGB-YUMQZZPRSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 102000014119 Nibrin Human genes 0.000 description 1
- 108050003990 Nibrin Proteins 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241001522306 Serinus serinus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- -1 carbomethoxy Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は新規なプリンヌクレオシドホスホリラーゼおよ
びその製造法に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel purine nucleoside phosphorylase and a method for producing the same.
(従来の技術)
これまでに、プリンヌクレオシドポスホリラーゼに関す
る報告は次のようなものがある。(Prior Art) To date, there are the following reports regarding purine nucleoside phosphorylases.
1、J、D、5toeckler、C,Cambor
and R,E、Parks、Jr、、[3ioc
hemistry−,19,102(192、T、U、
Utagawa、H,Mar i sawa、S、Ya
manaka、A、Yamazaki and 1
Y、Hfrose、、Agric。1, J, D, 5toeckler, C, Cambor
and R, E., Parks, Jr., [3ioc
hemistry-, 19, 102 (192, T, U,
Utagawa, H., Mar i sawa, S., Ya.
manaka, A, Yamazaki and 1
Y,Hfrose,,Agric.
Biol、Chem、、50.121 (1986)3
、Y、Machida and T、Nakani
shi、、Agric、Biol、Chem。Biol, Chem, 50.121 (1986) 3
, Y., Machida and T., Nakani.
shi, , Agric, Biol, Chem.
、45,1801.<1981>
(発明が解決しようとする課題)
前述のプリンヌクレオシドホスホリラーゼは耐熱性が低
いものであった。, 45, 1801. <1981> (Problems to be Solved by the Invention) The purine nucleoside phosphorylases described above had low thermostability.
本発明者らはこれまでに知られているプリンヌクレオシ
ドホスホリラーゼより、耐熱性にすぐれ、反応速度が速
い新規な酵素を提供することを目的として、鋭意研究を
進めた。The present inventors have conducted intensive research with the aim of providing a new enzyme that has better heat resistance and faster reaction rate than the previously known purine nucleoside phosphorylases.
(問題点を解決するための手段)
本発明のプリンヌクレオシドボスホリラーゼは以下の性
質を有する。(Means for solving the problems) The purine nucleoside bosphorylase of the present invention has the following properties.
■作用ニブリンヌクレオシド + Pi4\=−m−
塩基 士 リボース−1−リン酸
■基質特異性:アデニン、アデノシン以外のプリン系ヌ
クレオシドと塩基に対して作用する。■Action Nibrin nucleoside + Pi4\=-m- Base 2 Ribose-1-phosphate ■Substrate specificity: Acts on purine nucleosides and bases other than adenine and adenosine.
■至適1) Hおよび安定pH
至適pHはpH7〜11.5
pH7〜10において80℃の処理を30分しても失活
しない。(1) Optimum 1) H and stable pH The optimal pH is pH 7 to 11.5. At pH 7 to 10, it is not inactivated even after 30 minutes of treatment at 80°C.
■至適温度および作用適温の範囲
至適温度は80℃
pH7,0において50〜80℃では60分処理をして
も安定
pH7,0,80℃における半減期は16時間
(5):pH、温度などによる失活の条件:PH7,0
,90℃で処理しなとき20分で失活する。■Optimal temperature and range of action temperature Optimum temperature is 80℃ Stable at pH 7.0 and 50 to 80℃ even after 60 minutes of treatment Half-life at pH 7.0 and 80℃ is 16 hours (5): pH, Conditions for inactivation due to temperature, etc.: PH7.0
, deactivates in 20 minutes unless treated at 90°C.
■阻害、活性化および安定化 特別な活性化剤や安定化剤を必要としない。■Inhibition, activation and stabilization No special activators or stabilizers are required.
塩化第二水銀、パラクロロメルクリベンゾエイトにより
阻害を受ける。Inhibited by mercuric chloride and parachloromercribenzoate.
■分子量: 68000 (TSKゲルG−3000S
Wによるゲルr過法)
■サブユニットの分子量
34000 (SDS電気泳動法)
本発明のプリンヌクレオシドホスホリラーゼは至適pH
および安定pH,至適温度および作用適温の範囲におい
て、これまでに知られているものと性質を異にしている
。■Molecular weight: 68000 (TSK gel G-3000S
(Gel filtration method using W) ■Molecular weight of subunit: 34,000 (SDS electrophoresis method) The purine nucleoside phosphorylase of the present invention has an optimal pH.
The properties are different from those known so far in terms of stable pH, optimum temperature, and effective temperature range.
次に本発明の酵素の製造法について説明する。Next, the method for producing the enzyme of the present invention will be explained.
本発明において用いられる該酵素生産菌の好ましい例と
して本発明者らによって土壌中より分離されたバチルス
・ステアロサーモフィルスJTS859がある。この菌
株は、通商産業省工業技術院微生物工業研究所に寄託さ
れており、その寄託番号は、微工研藷寄第9666号(
FERM P−9666)である。A preferred example of the enzyme-producing bacterium used in the present invention is Bacillus stearothermophilus JTS859, which was isolated from soil by the present inventors. This strain has been deposited with the Institute of Microbiology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, and its deposit number is No. 9666 (
FERM P-9666).
この菌株の菌学的性質をパージエイズ・マニュアル第2
巻に準じて検討した結果を以下に示す。The mycological properties of this strain were determined in Purge Aids Manual No. 2.
The results of the study based on the volume are shown below.
■、形態 桿菌:5.4〜6.5μmX0.7〜0.9μ m 楕円形の胞子形成: 2.0〜2.3μmX 1 。■、Form Bacillus: 5.4-6.5μm x 0.7-0.9μm Oval sporulation: 2.0-2.3 μm x 1.
1〜1.2μm、l細胞
に1個、位置は末端
2、培養的性質
NB培地:62℃、2日間培養
平板上:白色5かに黄色を含む、光沢あり、不透明、盛
り上がらない、コロニ
ーの形は円形波状
スラント上:白色僅かに黄色を含む、光沢あり、不透明
、盛り−Eがらな
い、生育は中程度
3、生化学的性質
1 グラム染色
陽性
2 嫌気的培養
生育せず
運動性
オキシダーゼ
カタラーゼ
ゼラチンの液化
リドマスミルク
OFテスト
v−Pテスi・
グルコースからの
ガスの発生
グルコースからの
酸の産生
アラビノースからの
酸の産生
マニトールからの
酸の産生
キシロースからの
酸の産生
サブロー培地での生育
スラント
液体
あり、周毛
陽性
陽性
液化能あり
凝固させる
醗酵タイプ
陰性
発生せず
産生じた
産生ぜず
産生じた
産生ぜず
生育した
生育した
01001%リゾチーム
下での生育 生育せず
0.02%アザイド
下での生育 生育せず
7%NaC1
下での生育 生育せず
(2%まで生育した)
カゼインの加水分解 分解能あり
デンプンの加水分解 分解能あり
ジヒドロキシアセトン
の生成 生成せず
エラグヨーク試験 生育せず
クエン酸の利用 陰性
インドールの産生 陰性
ウレアーゼ活性 陽性
フェニルアラニンの
脱アミノ化 陰性
アルギニンデヒドロ
ラーゼ活性 陽性
チロシンの分解 陰性
29 レバン産生 陰性
30 硝酸塩の還元 陽性
31 ii酸ナトリウムの
脱窒能 陰性
32 硫化水素の生成 陽性
33 無al窒素源の利用
NOlを唯一の
窒素源として 生育した
NH,を唯一の
窒素源として 生育した
34 GC含量 47.3%35 生
育温度 40〜71℃で生育最適 60〜68℃
36 PH範囲 pH5,7〜8.5最適pH
6,0・〜7.0
以上の性質に基づき、本株菌はバチルス・ステアロサー
モフィルスと同定される。1 to 1.2 μm, 1 per cell, located at terminal 2, culture properties NB medium: 62°C, 2 days culture on plate: white with some yellow, glossy, opaque, not raised, colonies Shape is on a circular wavy slant: white with slight yellow, glossy, opaque, no ridges, growth is moderate 3, biochemical properties 1, Gram stain positive 2, anaerobic culture, no growth, motile oxidase catalase Liquefaction of gelatin Lidomus milk OF test v-P test i Gas generation from glucose Production of acid from glucose Production of acid from arabinose Production of acid from mannitol Production of acid from xylose Growth in Sabouraud medium With slant liquid , Perihair positive, positive, liquefaction ability, coagulation, fermentation type, negative, no production, no production, no production, no production, no growth, growth, growth under 01001% lysozyme, no growth, under 0.02% azide. Growth No growth, growth under 7% NaCl No growth (grown up to 2%) Hydrolysis of casein Hydrolysis of starch with decomposition ability Generation of dihydroxyacetone with decomposition ability No formation, Elaguyoke test No growth, use of citric acid Negative Production of indole Negative urease activity Deamination of positive phenylalanine Negative arginine dehydrolase activity Degradation of positive tyrosine Negative 29 Production of levane Negative 30 Reduction of nitrate Positive 31 Denitrification ability of sodium ii acid Negative 32 Production of hydrogen sulfide Positive 33 Al nitrogen free Source Utilization Grows with NOl as the only nitrogen source Grows with NH as the only nitrogen source 34 GC content 47.3% 35 Growth temperature Optimum growth at 40-71°C 60-68°C 36 PH range pH 5,7- 8.5 optimum pH
Based on the above properties, this strain is identified as Bacillus stearothermophilus.
上記株菌の培養に際しては、窒素源として、トリプトン
、ペプトンまたはカザミノ酸を、炭素源としてグルコー
スまたはシュークロースを含み、さらに酵母エキスと塩
化ナトリウムを含む培地を用いる。培養は60〜65℃
、180〜22Orpmで振どう培養するか、通気攪拌
培養により行う。When culturing the above-mentioned strain, a medium containing tryptone, peptone, or casamino acid as a nitrogen source, glucose or sucrose as a carbon source, and further containing yeast extract and sodium chloride is used. Culture at 60-65℃
, shake culture at 180 to 22 rpm or aerated agitation culture.
本発明における使用菌としては、バチルス・ステアロサ
ーモフィルスJTS859だけでなく、バチルス属に属
する前記した機能を持つプリンヌクレオシドホスホリラ
ーゼを生産する微生物であればすべて用いることができ
る。As the microorganism used in the present invention, not only Bacillus stearothermophilus JTS859 but also any microorganism belonging to the genus Bacillus that produces purine nucleoside phosphorylase having the above-mentioned functions can be used.
培養物よりプリンヌクレオシドホスホリラーゼの採取は
、次のようにして行う、集菌した菌体を破壊した後、熱
処理、アセトン処理、pH処理を順次はどこし、ついで
DEAE (ジエチルアミノエチル)陽イオン樹脂カラ
ム、CM(カルボメトキシ)陰イオン樹脂カラム、ブチ
ル基疎水クロマトカラム、フェニル基疎水クロマトカラ
ム、ヒドロキシアパタイトカラムおよびゲル濾過を行っ
て単離する。Purine nucleoside phosphorylase is collected from the culture as follows: After destroying the collected cells, heat treatment, acetone treatment, and pH treatment are performed in sequence, and then a DEAE (diethylaminoethyl) cation resin column is used. , CM (carbomethoxy) anion resin column, butyl group hydrophobic chromatography column, phenyl group hydrophobic chromatography column, hydroxyapatite column, and gel filtration for isolation.
本発明のプリンヌクレオシドホスホリラーゼを用い、プ
リン塩基とリン酸とからプリンヌクレオシトを効率よく
製造することができる。以下、本発明の実施例を示し、
さらに詳しく説明する。Purine nucleosides can be efficiently produced from purine bases and phosphoric acid using the purine nucleoside phosphorylase of the present invention. Examples of the present invention are shown below,
I will explain in more detail.
(実施例)
(実施例1)バチルス・ステアロサーモフィルス(Ba
ci l Ius、5te)JTS859の培養、集菌
ペプトン20g、イーストエキス10g、グリコース3
gおよび水11よりなるp)16.0の培地を用いた。(Example) (Example 1) Bacillus stearothermophilus (Ba
ci l Ius, 5te) Culture of JTS859, 20g of bacterial collection peptone, 10g of yeast extract, 3g of glycose
A medium of p) 16.0 consisting of 11 g and 11 g of water was used.
この培地2Iにバチルス・ステアロサーモフィルスJT
S859胞子3゜2X10’個を添加し、撹拌X(直径
60鴎、上下部各6枚)を有するジャーファメンターを
用い、撹拌翼を680 rpmで回転させつつ、通気量
1.5vvm、培養温度65℃、pH5,9〜6.2で
8時間培養した。Bacillus stearothermophilus JT in this medium 2I
Add 3°2 x 10' S859 spores, use a jar fermenter with stirring X (diameter 60 spores, 6 upper and lower each), rotate stirring blades at 680 rpm, aeration volume 1.5 vvm, and culture temperature. Culture was carried out at 65° C. and pH 5.9 to 6.2 for 8 hours.
培養終了後、菌体を遠心分1M!(10000g。After culturing, centrifuge the bacterial cells for 1M! (10000g.
4℃、15分)により集菌した。Bacteria were collected at 4°C for 15 minutes.
(実施例2)酵素の分離精製
得られた湿菌160gを500 m Mリン酸カリウム
(pH7,0,以下[M街液Jという)に懸濁し、ダイ
モミルで菌体を破壊した0M衡液を添加し、1400
mlとした後、遠心分離(8300g、20分)を行い
、上清1300mlを得た。沈澱物は500 mlの緩
衝液で懸濁し、ダイモミルで5分間処理した8M衡液を
添加し、10103Oとした後、遠心分離(8300g
、20分)を行い、上清990m1を得た。この上清9
90m1を先の上清1300ml’と合わせ、63℃で
1時I71!!やかに攪拌した。ついで、遠心分離(8
300g、40分)を行い、上清2130m1を得た。(Example 2) Separation and Purification of Enzyme 160 g of the obtained wet bacteria was suspended in 500 mM potassium phosphate (pH 7.0, hereinafter referred to as M street solution J), and a 0M equilibrium solution in which the bacterial cells were destroyed with Dymomill was added. Add, 1400
ml, centrifugation (8300 g, 20 minutes) was performed to obtain 1300 ml of supernatant. The precipitate was suspended in 500 ml of buffer, 8M equilibrated solution treated with Dymomil for 5 minutes was added to bring the temperature to 10103O, and then centrifuged (8300g
, 20 minutes) to obtain 990 ml of supernatant. This supernatant 9
Combine 90 ml with 1300 ml' of the supernatant from above and heat at 63°C for 1 hour. ! Stir vigorously. Then, centrifugation (8
300 g, 40 minutes) to obtain 2130 ml of supernatant.
熱処理をした上清2130m1にアセトン200m1と
緩衝液200m1の一10℃溶液を添加した。A 10° C. solution of 200 ml of acetone and 200 ml of buffer was added to 2130 ml of the heat-treated supernatant.
さらに、−10℃のアセトン1.8Nを加え、5〜10
℃で15分間攪拌した。つぎに、遠心分離(9000g
、5分)を行なった。得られた上清に一10℃のアセト
ン2.5Jを添加し15分間攪拌した後、遠心分離(9
000g、5分)を行ない沈澱物を得た。この沈澱物を
800m1の緩衝液に懸濁させアセトン処理済み酵素液
850m1を得た。Furthermore, add 1.8N of acetone at -10℃, and
Stirred at ℃ for 15 minutes. Next, centrifugation (9000 g
, 5 minutes). 2.5 J of acetone at -10°C was added to the obtained supernatant, stirred for 15 minutes, and then centrifuged (9
000 g for 5 minutes) to obtain a precipitate. This precipitate was suspended in 800 ml of buffer to obtain 850 ml of acetone-treated enzyme solution.
アセトン処理済みI9素液850m1に1Mリン酸を加
え、p Hを4.75として1111t間0℃に保った
。遠心分M(8900g、1時間)を行い、上清を得た
。この上清にIMの水酸化カリウムを加え、pHを7.
0に調整し840m1の酵素液を得た。1M phosphoric acid was added to 850ml of the acetone-treated I9 stock solution, the pH was adjusted to 4.75, and the mixture was kept at 0°C for 1111t. Centrifugation M (8900g, 1 hour) was performed to obtain a supernatant. IM potassium hydroxide was added to this supernatant to adjust the pH to 7.
The enzyme solution was adjusted to 0 and 840 ml of enzyme solution was obtained.
得られた酵素液840iをDEAE Toy。The obtained enzyme solution 840i was used as DEAE Toy.
pearl 650M(’東ソー製)200mlを充
填したカラム(Φ45X 126m)に添加した。It was added to a column (Φ45X 126m) packed with 200ml of Pearl 650M (manufactured by Tosoh).
ついで20mMのリン酸カリウムJPN液(p)17゜
0)2Mで溶出を行い、ついで20mMリン酸カリウム
と0.05M、0.1M、0.15M、0゜2M、0.
5Mの塩化ナトリウムよりなるpH7゜0の溶液各50
0m1を順次用いて溶出を続けた。Next, elution was performed with 20mM potassium phosphate JPN solution (p) 17°0) 2M, and then 20mM potassium phosphate and 0.05M, 0.1M, 0.15M, 0°2M, 0.
50 each of a solution of 5M sodium chloride at pH 7°0
Elution continued using 0 ml sequentially.
次に20mMリン酸カリウム、0.1M塩化ナトリウム
溶液の溶出画分500m1を1M水酸化カリウムでPH
8,0とした。この溶液& 2 Ont Mリン酸カリ
ウム、50mM塩化ナトリウムの溶液(pH8,0)で
平衡化したDEAE Toy。Next, 500ml of the eluate fraction of 20mM potassium phosphate and 0.1M sodium chloride solution was pH-treated with 1M potassium hydroxide.
It was set at 8.0. This solution & DEAE Toy equilibrated with a solution of 2 Ont M potassium phosphate, 50 mM sodium chloride (pH 8,0).
pear + 650M 400a+l (Φ3
1X530IIIII)のカラムに添加した。ついで2
0mMリン酸カリウム、50mM塩化ナトリウムの溶液
(pH8,0)11と、20mMリン酸カリウム、20
0mM塩化ナトリウム溶液(pH8,0)IJで塩化ナ
トリウム濃度が連続的に高くなるリニアーグラジェント
を作り、20m1づつ分取した。pear + 650M 400a+l (Φ3
1×530III) column. Then 2
0mM potassium phosphate, 50mM sodium chloride solution (pH 8,0) 11 and 20mM potassium phosphate, 20
A linear gradient in which the sodium chloride concentration continuously increases was prepared using IJ using 0 mM sodium chloride solution (pH 8,0), and 20 ml portions were collected.
プリンヌクレオシドホスホリラーゼ活性の認められた第
56〜63分画(166ml)を分取し、2M乳酸でp
H4,0とした。The 56th to 63rd fractions (166 ml) in which purine nucleoside phosphorylase activity was observed were collected and purified with 2M lactic acid.
It was set as H4.0.
この溶液を20mMリン酸カリウム、100mM塩化ナ
トリウム溶液(PH4,0)で平衡化したCM To
yopearl 650M(東ソー製)20ml(Φ
26X38膿)のカラムに添加した。ついで20mMリ
ン酸カリウム、100mM塩化ナトリウム溶液(P H
4、0) 20 +nl、20mMリン酸カリウム、4
00mM塩化ナトリウム溶液(pH4,0)100a+
I、20mMリン酸カリウム、500mM塩化ナトリウ
ム溶液(pH4゜0>100+alで順次溶出を続けた
。This solution was equilibrated with 20mM potassium phosphate and 100mM sodium chloride solution (PH4.0).
yopearl 650M (manufactured by Tosoh) 20ml (Φ
26×38 pus) was added to the column. Then, 20mM potassium phosphate, 100mM sodium chloride solution (PH
4,0) 20 +nl, 20mM potassium phosphate, 4
00mM sodium chloride solution (pH 4,0) 100a+
Elution was continued sequentially with I, 20mM potassium phosphate, 500mM sodium chloride solution (pH 4°0>100+al).
20mMリン酸カリウム、400mM塩化ナトリウム溶
液から活性画分50m1と得た。この溶液を2MKOH
でpH7,0に調整し、ついで硫安9.8gを添加し、
2MKOH’?″p)I7.Oに調整した。この溶液を
20mMリン酸カリウム、1.5M[安溶液(pH7,
0)で平衡化しなりutyl Toyopearl
650M(東ソー製)50ml(Φl 6 X 25
0 m )のカラムに添加した。50ml of active fraction was obtained from a 20mM potassium phosphate and 400mM sodium chloride solution. Add this solution to 2M KOH
The pH was adjusted to 7.0, and then 9.8 g of ammonium sulfate was added.
2MKOH'? "p)I was adjusted to 7.O. This solution was mixed with 20mM potassium phosphate, 1.5M
0) and then util Toyopearl
650M (manufactured by Tosoh) 50ml (Φl 6 x 25
0 m ) column.
20mMリン酸カリウム、1.5M硫安溶液(pH7,
0)50mlで溶出した。ついで1.5MK安を含む2
0mMリン酸カリウム125m1と20mMリン酸カリ
ウム溶液(pH7,0)125mlで硫安濃度が減少す
るリニアグラジェントを作り、溶出を行った。20mM potassium phosphate, 1.5M ammonium sulfate solution (pH 7,
0) Eluted in 50ml. Then 2 including 1.5MK decline
Elution was performed by creating a linear gradient with decreasing ammonium sulfate concentration using 125 ml of 0 mM potassium phosphate and 125 ml of 20 mM potassium phosphate solution (pH 7,0).
プリンヌクレオシドホスホリラーゼ活性の認められた画
分を、75mMリン酸カリウムに対し浸透した後、限外
f過で5mlに濃縮した。The fraction in which purine nucleoside phosphorylase activity was observed was permeated with 75 mM potassium phosphate and concentrated to 5 ml by ultraf.
ついで、TSKgel DEAE 5PW(東ソー
製) (Φ7.5X75m)を用い、リン酸カリウム溶
液(pH6,0>濃度を90mMより150mMまで1
5分間でリニアーグラジェントで濃度を増加させ、さら
に150mMで13分間溶出を行い、活性区分17.8
+alを得た。流速は1cl/分であった。Next, using TSKgel DEAE 5PW (manufactured by Tosoh) (Φ7.5X75m), a potassium phosphate solution (pH 6,0> concentration was adjusted from 90mM to 150mM).
Increasing the concentration with a linear gradient over 5 minutes and elution at 150mM for 13 minutes resulted in an activity fraction of 17.8.
+al was obtained. The flow rate was 1 cl/min.
得られた溶液を限外r過で4m口こ濃mtk、20mM
リン酸カリウムに硫安を飽和させた溶液2mlを添加し
た。ついで、TSKgel DEAE5pw(Φ7.
5X75−)を用い、20mMリン酸カリウム1.5M
[安から20mMリン酸カリウム7.5Mi安まで60
分間でリニアーグラジェントで硫安濃度0.75Mで1
5分間流出させ、活性区分26m1を得た。流速は1m
l/分であった。The resulting solution was ultrafiltered to a concentration of 4 mtk, 20 mM.
2 ml of ammonium sulfate saturated solution of potassium phosphate was added. Next, TSKgel DEAE5pw (Φ7.
5X75-), 20mM potassium phosphate 1.5M
[From low to 20mM potassium phosphate 7.5Mi low 60
1 at ammonium sulfate concentration of 0.75M with a linear gradient in minutes.
After 5 minutes of runoff, 26 ml of active compartment was obtained. Flow velocity is 1m
It was 1/min.
つぎにこの活性区分26m1をTSKgel HAl
oo(Φ7.5X75鵬、東ソー製)を用い、リン酸カ
リウム溶液(pH6,8)の濃度を90mMより100
mMまで10分間でリニアーグラジェントで増加させ、
さらに100mMt”10分間溶出を行い、本発明のプ
リンヌクレオシドホスホリラーゼ1.7■を得た。流速
はla+l/分であった。Next, 26m1 of this active section was treated with TSKgel HAl.
oo (Φ7.5X75, manufactured by Tosoh), the concentration of potassium phosphate solution (pH 6,8) was adjusted from 90mM to 100mM.
Increased with a linear gradient in 10 min to mM,
Further elution was performed for 10 minutes at 100mMt'' to obtain 1.7cm of the purine nucleoside phosphorylase of the present invention.The flow rate was la+l/min.
(実施例3)理化学的性質
0作用および基質特異性
本発明のプリンヌクレオシドホスポリラーゼ0゜02M
gを含む20mMヌクレオシド2QmMリン酸カリウム
溶液(pH7,0)200ujを60℃で10分間反応
させ、生成した塩基を定すした。結果を表1に示す。(Example 3) Physicochemical properties 0 Effect and substrate specificity Purine nucleoside phosporylase of the present invention 0°02M
200 uj of 20 mM nucleoside 2QmM potassium phosphate solution (pH 7,0) containing g was reacted at 60° C. for 10 minutes, and the generated base was determined. The results are shown in Table 1.
また本発明のプリンヌクレオシドホスホリラーゼ0.0
2Mg、20mM塩基、20mMリボース−1−ホスフ
ェート、20mMリン酸カリウムよりなる溶液(p)1
7.0)200μmを60℃で10分間反応させ、生成
したヌクレオシドを定量した。結果を表2に示す。Moreover, the purine nucleoside phosphorylase of the present invention 0.0
Solution (p) 1 consisting of 2Mg, 20mM base, 20mM ribose-1-phosphate, 20mM potassium phosphate
7.0) 200 μm was reacted at 60° C. for 10 minutes, and the produced nucleoside was quantified. The results are shown in Table 2.
(以下余白)
ヌクレオシド
イノシン
アデノシン
グアノシン
キサンチン
シチジン
ウリジン
5−・メチルウリジン
2−−デオキシイノシン
2−−デオキシアデノシン
2゛−デオキシグアノシン
チミジン
2−−デオキシウリジン
2゛−デオキシシチジン
生成塩基量
0.22mM
0.18
0.10
0.46
0.33
表2
塩基 生成ヌクレオシドヒボキサンチ
ン C169mMアデニン
O
キサンチン 0,52
シトシン 0
ウラシル 0
チミン 0
■至適pHおよび安定pH
本発明のプリンヌクレオシドホスホリラーゼ0゜68μ
gを含む20mMイノシン、20mMリン酸カリウム溶
液(pH3,5〜13)5mlを60℃で15分間反応
させた。生成したヒボキサンチンを図1に示す、pH7
から11.5の間において高い酵素活性が認められた。(Left below) Nucleoside inosine adenosine anosine xanthine cytidine uridine 5-/methyluridine 2--deoxyinosine 2--deoxyadenosine 2'-deoxyguanosine thymidine 2--deoxyuridine 2'-deoxycytidine Amount of base produced 0.22mM 0. 18 0.10 0.46 0.33 Table 2 Base Generated nucleoside hyboxanthin C169mM adenine
O Xanthine 0,52 Cytosine 0 Uracil 0 Thymine 0 ■Optimal pH and stable pH Purine nucleoside phosphorylase of the present invention 0°68μ
5 ml of a 20 mM inosine, 20 mM potassium phosphate solution (pH 3.5 to 13) containing g was reacted at 60° C. for 15 minutes. The produced hyboxanthin is shown in Figure 1, pH 7
High enzyme activity was observed between 11.5 and 11.5.
安定p Hを調べるために本発明のプリンヌクレオシド
ホスホリラーゼ0.17μgを50μmの20mMクエ
ン[1衡液(20mMリン酸カリウムを含む)=20m
MグリシンMffr液(20mMリン酸カリウムを含む
)、20mM)リス・塩酸緩衝液(20mMリン酸カリ
ウムを含む)、20mMリン酸カリウムM衡液中各々8
0℃で300分間反応せ、残存酵素活性を定量した。結
果を図2に示す。To check the stable pH, 0.17 μg of the purine nucleoside phosphorylase of the present invention was added to 50 μM of 20 mM citric acid [1 equilibration (containing 20 mM potassium phosphate) = 20 m
8 each in Mglycine Mffr solution (containing 20mM potassium phosphate), 20mM) Lis-HCl buffer (containing 20mM potassium phosphate), 20mM potassium phosphate M solution
The reaction was carried out at 0°C for 300 minutes, and the residual enzyme activity was quantified. The results are shown in Figure 2.
酵素活性はpH7〜10においても失活しなかった。Enzyme activity was not inactivated even at pH 7-10.
■至適温度および作用適温の範囲
本発明のプリンヌクレオシドホスホリラーゼ0.085
ugを含む20mMイノシン、20mMリン酸カリウム
溶液(pH7,0)1mlを40〜90℃で反応させ、
生成したヒボキサンチンを定量した。結果を図3に示す
。■Optimum temperature and range of action temperature Purine nucleoside phosphorylase of the present invention 0.085
1 ml of 20mM inosine and 20mM potassium phosphate solution (pH 7,0) containing ug was reacted at 40 to 90°C,
Hyboxanthin produced was quantified. The results are shown in Figure 3.
80℃以下では温度が高いほど生成速度が速く290℃
では20分以内に酵素が失活した。Below 80°C, the higher the temperature, the faster the production rate is at 290°C.
The enzyme was deactivated within 20 minutes.
また、20mMリン酸カリウムとZmMイノシン溶液(
pH7,0)中での酵素の半減期は、図4に示ように1
6時間であった。In addition, 20mM potassium phosphate and ZmM inosine solution (
The half-life of the enzyme at pH 7,0) is 1 as shown in Figure 4.
It was 6 hours.
■阻害、活性化および安定化
本発明のプリンヌクレオシドホスホリラーゼ0゜09μ
gを含む20mMイノシン、20mMリン酸カリウム溶
液と各種金属イオン溶液(pH7゜0)1mlを60℃
で20分反応させ、生成したヒボキサンチンを定量した
。■Inhibition, activation and stabilization of the purine nucleoside phosphorylase of the present invention 0°09μ
20mM inosine containing g, 20mM potassium phosphate solution and 1ml of various metal ion solutions (pH 7°0) at 60°C.
The mixture was reacted for 20 minutes, and the produced hyboxanthin was quantified.
Mg5Oa −7H20、MnCjl x ’ 4H,
01CuSOa ’ 5Hx 01ZnSOa ・7H
z 01CH* I C0OH,EDTA、では阻害は
認められなかったが、Hg Cj x 、パラクロロメ
ルクリベンゾエイトでは強い阻害が認められた。Mg5Oa-7H20, MnCjl x' 4H,
01CuSOa' 5Hx 01ZnSOa ・7H
No inhibition was observed with z 01CH* I C0OH and EDTA, but strong inhibition was observed with Hg Cj x and parachloromercribenzoate.
■分子量
TSKゲルG−3000SW(束ンー製)によるゲルr
過法では68000であった。■Gel r using molecular weight TSK Gel G-3000SW (manufactured by Takun)
Under the law, it was 68,000.
SDS電気泳動法によるサブユニットの分子量は340
00であ・ンな。The molecular weight of the subunit by SDS electrophoresis is 340
It's 00.
■アミノ酸組成
アミノ酸アナライザー(日立IJ8835)により分析
した。結果を表3に示す。(2) Amino acid composition Analyzed using an amino acid analyzer (Hitachi IJ8835). The results are shown in Table 3.
表3 構成アミノ酸 アスパラギン酸 スレオニン セリン グルタミン酸 グリシン アラニン バリン メチオニン イソロイシン ロイシン チロシン フェニルアラニン リジン ヒスチジン アルギニン プロリン Mol % 8、04 4、30 3、08 12.64 10.07 10.80 8、59 3、68 8、55 7、26 3、26 2、32 4 、07 5、96 5、49Table 3 Constituent amino acids aspartic acid Threonine Serin glutamic acid glycine alanine Valine methionine isoleucine Leucine Tyrosine Phenylalanine lysine histidine arginine proline Mol% 8,04 4, 30 3,08 12.64 10.07 10.80 8, 59 3,68 8, 55 7, 26 3, 26 2, 32 4, 07 5,96 5, 49
第1図は本発明のプリンヌクレオシドホスホリラーゼの
pH依存性を示す図面である。
第2図は本発明のプリンヌクレオシドホスホリラーゼの
pH安定性を示す図面である。
第3図は作用適温の範囲を示す図面である。
第4図は酵素活性の半減期を示す図面である。
第
図
度忘・時間 (分)FIG. 1 is a drawing showing the pH dependence of the purine nucleoside phosphorylase of the present invention. FIG. 2 is a diagram showing the pH stability of the purine nucleoside phosphorylase of the present invention. FIG. 3 is a diagram showing the range of suitable temperature for action. FIG. 4 is a diagram showing the half-life of enzyme activity. Number of minutes / Time (minutes)
Claims (1)
ホリラーゼ (1)作用:プリンヌクレオシド+Pi■ 塩基+リボース−1−リン酸 (2)基質特異性:アデニン、アデノシン以外のプリン
系ヌクレオシドと塩基に対して作用する。 (3)至適pHおよび安定pH 至適pHはpH7〜11.5 pH7〜10において80℃の処理を30 分しても失活しない。 (4)至適温度および作用適温の範囲 至適温度は80℃、pH7.0において5 0〜80℃では60分処理をしても安定 (5):pH、温度などによる失活の条件:pH7.0
、90℃で処理したとき20分 で失活する。 (6)阻害、活性化および安定化 特別な活性化剤や安定化剤を必要としない。 塩化第二水銀、パラクロロメルクリベンゾエイトにより
阻害を受ける。 (7)分子量:68000(TSKゲルG−3000S
Wによるゲル濾過法) (8)サブユニットの分子量 34000(SDS電気泳動法) 2、請求項1項に記載の酵素を生産する能力を有するバ
チルス属に属する微生物を培養し、培養物より該酵素を
採取することを特徴とするプリンヌクレオシドホスホリ
ラーゼの製造法。[Claims] 1. Purine nucleoside phosphorylase having the following physical and chemical properties (1) Action: Purine nucleoside + Pi base + ribose-1-phosphate (2) Substrate specificity: Purine nucleosides other than adenine and adenosine and acts on bases. (3) Optimum pH and Stable pH The optimal pH is pH 7 to 11.5. At pH 7 to 10, it is not inactivated even after 30 minutes of treatment at 80°C. (4) Range of optimal temperature and action temperature The optimal temperature is 80°C and pH 7.0 at 50°C. Stable even after 60 minutes of treatment at 80°C to 80°C. (5) Conditions for inactivation depending on pH, temperature, etc.: pH7.0
, it is deactivated in 20 minutes when treated at 90°C. (6) Inhibition, activation and stabilization No special activators or stabilizers are required. Inhibited by mercuric chloride and parachloromercribenzoate. (7) Molecular weight: 68000 (TSK gel G-3000S
(Gel filtration method using W) (8) Molecular weight of subunit: 34,000 (SDS electrophoresis method) 2. A microorganism belonging to the genus Bacillus having the ability to produce the enzyme according to claim 1 is cultured, and the enzyme is extracted from the culture. 1. A method for producing purine nucleoside phosphorylase, which comprises collecting .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4020889A JP2548356B2 (en) | 1989-02-22 | 1989-02-22 | Brin nucleoside phosphorylase and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4020889A JP2548356B2 (en) | 1989-02-22 | 1989-02-22 | Brin nucleoside phosphorylase and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH02222677A true JPH02222677A (en) | 1990-09-05 |
| JP2548356B2 JP2548356B2 (en) | 1996-10-30 |
Family
ID=12574365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4020889A Expired - Lifetime JP2548356B2 (en) | 1989-02-22 | 1989-02-22 | Brin nucleoside phosphorylase and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2548356B2 (en) |
-
1989
- 1989-02-22 JP JP4020889A patent/JP2548356B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2548356B2 (en) | 1996-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS62289A (en) | Enzymatic production of l-alpha-amino acid from alpha-ketoic acid | |
| CZ296356B6 (en) | Process for preparing purine nucleoside compound | |
| JP2795748B2 (en) | Method for producing nucleoside | |
| JP3834960B2 (en) | Method for producing D-amino acid | |
| JPH02222677A (en) | Purine nucleoside phosphorylase and production thereof | |
| JPS611384A (en) | Preparation of n-acetylneuraminic lyase | |
| EP0129119A2 (en) | Method for producting L-aspartic acid | |
| JPH044888A (en) | Production of amino acid by fermentation | |
| JPH0515369A (en) | Novel pullulanase and method for producing the same | |
| JP2547438B2 (en) | Method for producing nucleoside compound | |
| JP3799784B2 (en) | Process for producing 2,6-diaminopurine-2'-deoxyriboside and 2'-deoxyguanosine | |
| JP2544480B2 (en) | Purine nucleoside phosphorylase and method for producing the same | |
| EP0206595B1 (en) | Thermally stable tryptophanase process for producing the same, and thermally stable tryptophanase-producing microorganism | |
| JP2800187B2 (en) | Method for producing 5-methyluridine | |
| JP3735956B2 (en) | Xanthine dehydrogenase and method for producing the enzyme | |
| JPS6058068A (en) | Novel amine dehydrogenase and oxidation of amine using it | |
| JP2565572B2 (en) | Pyrimidine nucleoside phosphorylase and method for producing the same | |
| SU1650697A1 (en) | The strain of bacteria BacILLUS LI сННI FоrmIS - producing restrictase B @ 13I | |
| Tachiki et al. | Purification, properties and formation of arginine-α-ketoglutarate transaminase in Arthrobacter simplex | |
| EP0159866A2 (en) | Process for production of L-amino acids | |
| JPS63313580A (en) | Formic acid dehydrogenase | |
| JPH0630573B2 (en) | L-phenylalanine dehydrogenase and method for producing the same | |
| KR970002253B1 (en) | Microorganisms Producing 5'-Guanylic Acid | |
| JPH0335915B2 (en) | ||
| JPH0630572B2 (en) | L-phenylalanine dehydrogenase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080808 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090808 Year of fee payment: 13 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090808 Year of fee payment: 13 |